You searched for "learning"

3297 results found

Bevacizumab, NF2, hearing and age

Introduction NF2-related schwannomatosis (NF2-SWN) is an autosomal dominant disorder leading to the development of schwannomas, meningiomas and spinal cord ependymomas. Younger age is a negative prognostic factor. Treatment includes observation, surgery, radiotherapy and medical therapy with bevacizumab (VEGF monoclonal antibody)....

Implantable Hearing Devices

Implantable Hearing Devices is aimed principally at ENT surgeons in training and as a resource for otological surgeons wanting to know more about the devices available. The authors state it is a clear, concise, and comprehensive book offering answers to...

Dispelling myths about audiologic counselling: part one

In the first of a two-part series (see Part 2 here), Drs Clark and English explore common misconceptions in audiologic counselling and highlight the power of empathy and person-centred care. As patients sit before us, they experience any number of...

Nottingham hearing experts launch CHEAR (COVID and hearing) study

Researchers based in Nottingham are launching an in-depth and ongoing study into the possible effects of COVID-19 on patients’ hearing, tinnitus and balance. The CHEAR (COVID and hearing, otherwise known as ‘Measuring Hearing, Tinnitus and Balance following COVID-19’) Study will...

The power of mentoring

What is a mentor, and what are the benefits for mentee and mentor? Emma Stapleton and Rohma Abrar, mentor and mentee respectively, explain. The term ‘mentor’ is derived from Homer’s Odyssey, in which the goddess Athena, disguised as Mentor, guides...

From Irish innovation to Global impact: Tympany Medical seeks investors

Irish MedTech pioneer Tympany Medical has launched a €600,000 crowdfunding campaign via Crowdcube under the Employment and Investment Incentive Scheme (EIIS), offering a 50% tax rebate for Irish taxpayers. The campaign invites both seasoned and first-time investors to back innovation...

The future of treatments for hearing and balance: a 15 and 50-year perspective

Jameel Muzaffar and Manohar Bance paint a picture of what otology will look like 15 and 50 years’ time. Will we still need doctors? Will there still be an ENT news journal? The last 50 years have seen advances including...

Will it ever happen?

Audiology is a rapidly evolving field, with many exciting developments on the horizon. David Baguley identified some topics of interest, and asked some international experts ‘will it ever happen?’ Gene therapy for deafness After years of development, gene therapy for...

Fundamentals of AAC – A Case-Based Approach to Enhancing Communication

A comprehensive text that will appeal to speech and language therapists at all stages of their careers, from undergraduate through to seasoned professionals working directly in the field. Despite there being 64 contributors (mostly from the US), the editors have...

Genetic research on hereditary hearing loss and clinical application in the Chinese population

Congenital deafness in China affects more people than the entire population of Australia. Prof Wang give us a comprehensive insight into one of the main congenital disabilities in China, looking into the causes of deafness and the benefits of genetic...

Overcoming barriers to ear health in remote WA: partnerships and mobile care

Earbus Foundation delivers culturally safe, mobile ear healthcare to Aboriginal children across remote Western Australia, bridging access gaps. Otitis media, or middle ear disease, is highly prevalent in Aboriginal children in Australia [1]. Studies have shown that otitis media can...

The connection between hearing loss and cognitive decline: current perspectives

Editorial clarification This article reviews research exploring associations between hearing impairment, cognitive decline and dementia. While evidence shows a dose-dependent relationship, it is important to note that association does not prove causation, and current research does not definitively show if...